Weinhoff Gregory M — SEC Form 4 filings
SEC reporting owner CIK 1400975. 24 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-02-02 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 16 filings — 305,533 shares, $5,802,052 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 61,253 shares @ $26.17 ($1,602,795) in Centessa Pharmaceuticals plc, filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) | Chief Business Officer | 24 | — | 18 legs · 305,533 sh · $5,802,052 | 38 |
Form 4 filings — Weinhoff Gregory M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | Centessa Pharmaceuticals plc (CNTA) | Disposition to issuer (D): 65,925 · Disposition to issuer (D): 584,321 (derivative) · Disposition to issuer (D): 230,000 (derivative) · Disposition to issuer (D): 31,002 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · +2 more | EDGAR |
| 2026-03-26 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 23,998 @ $3.85 · Sale (S): 23,998 @ $30 · Option exercise (M): 23,998 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 61,253 @ $26.17 · Sale (S): 11,943 @ $27.16 | EDGAR |
| 2026-02-03 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 14,158 @ $24.57 · Grant/award (A): 31,000 @ $0 · Grant/award (A): 123,000 (derivative) @ $0 | EDGAR |
| 2025-07-25 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 10,000 @ $3.85 · Sale (S): 10,000 @ $15.56 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 10,000 @ $3.85 · Sale (S): 10,000 @ $13.86 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 10,000 @ $3.85 · Sale (S): 10,000 @ $12.82 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 11,742 @ $13.61 | EDGAR |
| 2025-03-26 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 10,000 @ $3.85 · Sale (S): 10,000 @ $16.34 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 11,494 @ $15.25 | EDGAR |
| 2025-02-04 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 14,267 @ $16.92 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 11,742 @ $16.47 | EDGAR |
| 2024-12-31 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 11,742 @ $16.35 | EDGAR |
| 2024-12-26 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 10,000 @ $3.85 · Sale (S): 10,000 @ $17.04 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 10,000 @ $3.85 · Sale (S): 10,000 @ $17.66 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-10-25 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 11,742 @ $15.38 | EDGAR |
| 2024-10-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 11,742 @ $15.79 | EDGAR |
| 2024-09-27 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 16,619 @ $15.69 | EDGAR |
| 2024-09-12 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 30,000 @ $5.84 · Sale (S): 30,000 @ $17 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-09-09 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 25,000 @ $5.84 · Sale (S): 25,000 @ $15 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-23 | 4 | Centessa Pharmaceuticals plc (CNTA) | Sale (S): 12,198 @ $12.17 · Sale (S): 17,802 @ $12.29 | EDGAR |
| 2024-07-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 11,742 @ $9.03 | EDGAR |
| 2024-04-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 11,742 @ $11.30 | EDGAR |
| 2024-02-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Grant/award (A): 31,250 @ $0 · Tax withholding (F): 11,494 @ $8.19 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1400975 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →